Tinidazole: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{TINDAMAX}} | ||
{{CMG}} | {{CMG}} | ||
| Line 11: | Line 11: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[ | ''' [[TINDAMAX description|Description]]''' | ||
'''| [[ | '''| [[TINDAMAX clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[TINDAMAX microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[TINDAMAX indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[TINDAMAX contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[TINDAMAX warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[TINDAMAX adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[TINDAMAX drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[TINDAMAX overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[TINDAMAX clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[TINDAMAX dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[TINDAMAX how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[TINDAMAX labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 18:53, 7 January 2014
Template:TINDAMAX Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
TINDAMAX®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages